Ana Sandoiu writing for MedicalNewsToday reports that a new study evidences a synthetic analog of a compound found in a rare Chinese tree can be utilized to address treatment-resistant pancreatic cancer. The article highlights that approximately 55,440 people will develop pancreatic cancer in 2018 and about 44,330 will die as a result. The cancer is difficult to both diagnose and treat. Patients often discover they have the disease during later stages which adversely impacts patient options.
A derivative of campthothecin—a Chinese tree bark—can kill pancreatic cancer tumors.
Fengzhi Li, PhD, associate professor of oncology, Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center